TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) just unveiled an update.
Zylox-Tonbridge Medical Technology Co., Ltd. has announced an upcoming board meeting scheduled for April 25, 2025. The meeting will address the recommendation for the payment of a final dividend for the year ending December 31, 2024, among other business matters, potentially impacting shareholder returns and company financial strategies.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the medical technology industry. The company is listed on the Hong Kong Stock Exchange and focuses on developing and providing advanced medical devices.
YTD Price Performance: 29.23%
Average Trading Volume: 141
Technical Sentiment Signal: Strong Sell
Current Market Cap: €580.8M
See more data about 2190 stock on TipRanks’ Stock Analysis page.